Continuum Advisory »

Abcellera Biologics shares owned by Continuum Advisory

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Continuum Advisory from 13F filings

Historical chart of Continuum Advisory investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Continuum Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Continuum Advisory

Quarter filed Position value Share count Share price at filing
2024-03-31 $366 93 3.95

More positions owned by Continuum Advisory

Capital Group Dividend Value Etf Etf (CGDV)
Apple Stock (AAPL)
Jpmorgan Core Plus Bond Etf Jpmorgan Core Plus Bond Fund Etf (JCPB)
Microsoft Corp Stock (MSFT)
Vanguard Extended Market Etf Etf (VXF)
Vanguard Total Stock Market Etf Etf (VTI)
Ishares 20 Year Treasury Bond Etf Etf (TLT)
Invesco Qqq Trust Series I Etf (QQQ)
Amazon Stock (AMZN)
Vanguard Total Bond Market Etf Etf (BND)
Barnes Group Stock (B)
Spdr Msci Usa Strategicfactors Etf Etf (QUS)
Vanguard Large-cap Etf Etf (VV)
Ishares S&p 100 Etf Etf (OEF)
Ishares Core S&p 500 Etf Etf (IVV)

View all positions for Continuum Advisory

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Baillie Gifford & Co
Ing Investment Management
Capital World Investors
Credit Suisse
OrbiMed Advisors
Arrowpoint Asset Management
BlackRock
Founders Fund VII Management
Federated Investors
Casdin Capital
Lazard Asset Management
Prosight Management
Guardian Capital Advisors
Two Sigma Advisers

View all funds holding Abcellera Biologics